Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.
EXPRESS: Neuroprotection with delayed maturation of oligodendrocytes after therapeutic hypothermia for mild cerebral ischemia in near-term fetal sheep.
Irisin as a driver of neuroprotection in multiple sclerosis.
Insulin Resistance as a Mediator of Suicide Risk in Bipolar Disorder: A Neurobiological and Imaging Study.
Tryptophan 2,3-dioxygenase deficiency attenuates dextran sodium sulphate -induced ulcerative colitis in mice by suppressing macrophage polarisation and reducing intestinal epithelial cell apoptosis.
Atypical Unilateral-Onset Guillain-Barré Syndrome Mimicking Acute Stroke: A Case Report.
Disability profiles in progressive multiple sclerosis reflect pathology distribution, independent of clinical phenotype.
Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea.
Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.
Paeonia lactiflora-derived extracellular vesicles ameliorate diabetic peripheral neuropathy by modulating chemokine-guided immune trafficking in peripheral nerves.
Aging beyond diagnosis: the MRI brain age gap across disorders.
Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trial.
Mechanistic Insights and Therapeutic Potential of MCC950 as a NLRP3 Inflammasome Inhibitor in Multiple Sclerosis: A Narrative Review.
Explainable Artificial Intelligence to Predict Neurocognitive Disorder Progression in Multiple Sclerosis Using MRI and Clinical Data.
7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs.
GABAB receptors in glial cells: from physiological regulation to pathological implications.
Long-term organophosphate exposure leading to delayed neuropathy in a pesticide applicator: a case report.
Correction to "Severe Hyponatremia in the Emergency Department. Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome".
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease.
The Pivotal Roles of Macrophages and Microglia in Mesenchymal Stromal/Stem Cell-Derived Small Extracellular Vesicle-Mediated Tissue Repair After Spinal Cord Injury.
Use of semaglutide and tirzepatide among people with multiple sclerosis.
Dynamic characterization of pathological and functional deterioration in a mouse model of optic neuritis related to neuromyelitis optica spectrum disorder.
Impaired P3 encoding and frontoparietal network imbalance characterize visual working memory deficits in newly diagnosed patients with multiple sclerosis: multimodal evidence from electrophysiology and structural neuroimaging.
The meningeal lymphatic vessel-peripheral immune axis: a novel therapeutic target in neurodegenerative diseases.
Immunotherapy-Mediated Modulation of the Gut Microbiota in Multiple Sclerosis: The Effects of High-Efficacy (Cladribine) and Moderate-Efficacy (Interferon Beta-1a) Treatments.
Pages
« first
‹ previous
…
821
822
823
824
825
826
827
828
829
…
next ›
last »